Prediction of tumor heterogeneity in localized prostate cancer

被引：6

作者：

Huland, H

Graefen, M

Haese, A

Hammerer, PG

Palisaar, J

Pichlmeier, U

Henke, RP

Erbersdobler, A

Huland, E

Lilja, H

机构：

[1] Univ Clin Hamburg, Hosp Eppendorf, Dept Urol, D-20246 Hamburg, Germany

[2] Univ Clin Hamburg, Hosp Eppendorf, Dept Biostat, D-20246 Hamburg, Germany

[3] Univ Clin Hamburg, Hosp Eppendorf, Inst Pathol, D-20246 Hamburg, Germany

[4] Lund Univ, Dept Clin Chem, S-20502 Malmo, Sweden

来源：

UROLOGIC CLINICS OF NORTH AMERICA | 2002年 / 29卷 / 01期

关键词：

D O I：

10.1016/S0094-0143(02)00006-X

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The clinical T1-T2 prostatic carcinoma is a heterogeneous tumor in respect to pathologic stage and outcome. Tumor heterogeneity can be fairly good predicted by the use of classification and regression tree analysis with preoperative parameters, especially a quantitative analysis of Gleason grade 4-5 cancer in six systematic biopsies and a determination of preoperative prostate-specific antigen levels, to predict lymph node status, capsular penetration, and outcome.

引用

页码：213 / +

页数：11

共 50 条

[31] Localized prostate cancer
Krongrad, A
UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (02) : XV - XV
[32] Localized cancer of the prostate
Mottet, N
EUROCANCER 98, 1998, : 335 - 336
[33] Localized prostate cancer
Kapoor, Anil
Hotte, Sebastien J.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2016, 10 (7-8): : S138 - S139
[34] Development of Integrated Data and Prediction System Platform for the Localized Prostate Cancer
Lee, Sun Jung
Yu, Sung Hye
Kim, Yejin
Hong, Jun Hyuk
Kim, Choung-Soo
Seo, Seong Il
Jeong, Chang Wook
Byun, Seok-Soo
Ha Chung, Byung
Lee, Ji Youl
Choi, In Young
MEDINFO 2019: HEALTH AND WELLBEING E-NETWORKS FOR ALL, 2019, 264 : 1506 - 1507
[35] PROSTATE CANCER Intrapatient heterogeneity in prostate cancer
Beltran, Himisha
Demichelis, Francesca
NATURE REVIEWS UROLOGY, 2015, 12 (08) : 430 - 431
[36] Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
Kikuchi, E
Scardino, PT
Wheeler, TM
Slawin, KM
Ohori, M
JOURNAL OF UROLOGY, 2004, 172 (02): : 508 - 511
[37] Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
Broncy, Lucile
Paterlini-Brechot, Patrizia
CELLS, 2019, 8 (07)
[38] Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer
Parker, C
Milosevic, M
Toi, A
Sweet, J
Panzarella, T
Bristow, R
Catton, C
Catton, P
Crook, J
Gospodarowicz, M
McLean, M
Warde, P
Hill, RP
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 750 - 757
[39] EVALUATION OF A NEW TUMOR-MARKER FOR LOCALIZED PROSTATE-CANCER
CULKIN, DJ
GELDER, FB
VICK, SR
PARRA, BL
MATA, JA
VENABLE, DD
ZITMAN, RA
PROSTATE, 1992, 20 (02): : 117 - 122
[40] Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
Kikuchi, E
Ohori, M
Wheeler, TM
Slawin, KM
Scardino, PT
JOURNAL OF UROLOGY, 2004, 171 (04): : 210 - 210

← 1 2 3 4 5 →